Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis.
BACKGROUND:Pulmonary hypertension (PH) due to left heart failure (HF) is the most common form of PH. However, treatment is unclear because there are conflicting results about safety and efficacy of PH-targeted therapies. OBJECTIVES:To assess the effects of PH-targeted therapy on exercise capacity in...
Main Authors: | Charles-Antoine Guay, Louis-Vincent Morin-Thibault, Sebastien Bonnet, Yves Lacasse, Caroline Lambert, Jean-Christophe Lega, Steeve Provencher |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6181322?pdf=render |
Similar Items
-
Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
by: Annie C. Lajoie, et al.
Published: (2018-05-01) -
Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries
by: Steeve Provencher, et al.
Published: (2024-03-01) -
COVID-19 and the pulmonary vasculature
by: Steeve Provencher, et al.
Published: (2020-06-01) -
Alternatives to the six-minute walk test in pulmonary arterial hypertension.
by: Vincent Mainguy, et al.
Published: (2014-01-01) -
Pulmonary micro-tumor emboli resulting in paradoxical emboli: a case report
by: Louis-Vincent Morin-Thibault, et al.
Published: (2018-02-01)